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Background/Aims: Deterioration of renal function in 
cirrhotic patients with spontaneous bacterial peritonitis 
(SBP) is a predictor for in-hospital mortality; however, 
the clinical significance of renal dysfunction during 
bacterial infection other than SBP is unknown. The 
aim of this study was to investigate the prevalence 
and clinical significance of renal dysfunction due to 
bacterial infections other than SBP in patients with liv-
er cirrhosis. Methods: Retrospective data from in-
patients with bacterial infections other than SBP were 
analyzed.  Results: Eighty patients were recruited for 
the analysis. The types of infections included that of 
urinary tract (37.5%), pneumonia (23.8%), biliary tract 
(20%), cellulitis (12.5%), and bacteremia of unknown 
origin (6.3%). Renal dysfunction developed in 29 pa-
tients (36.3%), of which 11 patients had irreversible 
renal dysfunction. The initial MELD score, neutrophil 
count, albumin, and blood pressure were significant 
risk factors in the univariate analysis, whereas only 
the MELD score was an independent risk factor for 
the development of renal dysfunction (p＜0.001) after 
multivariate analysis. Conclusions: The prevalence of 
renal dysfunction during bacterial infection other than 
SBP in patients with liver cirrhosis was 36.3%, and its 
development was related to the severity of the liver 
disease. Occurrence of irreversible renal dysfunction 
seemed to affect the prognosis of these patients. 
(Gut and Liver 2009;3:292-297)
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INTRODUCTION
  Bacterial infection is a complication that occurs at a 
higher incidence in patients with liver cirrhosis.
1-4 In par-
ticular, cases in which renal dysfunction occurs during 
the course of bacterial infection have a poor prognosis, 
and renal dysfunction is a key indicator predicting death 
in patients with bacterial infection.
1 Bacterial infections 
commonly observed in patients with liver cirrhosis are, in 
descending order of frequency, urinary tract infection, 
pneumonia, and spontaneous bacterial peritonitis (SBP).
5-8
  Most of the studies concerned about the clinical sig-
nificance of renal dysfunction in patients with SBP.
9-11 In 
patients with bacterial infection other than SBP, despite 
its higher prevalence, the clinical significance of renal dys-
function which might have the same pathophysiology as 
SBP, has not been thoroughly examined.
  The objectives of this study were to examine the in-
cidence of renal dysfunction in the presence of bacterial 
infections other than SBP and to evaluate the incidence, 




  The current study included patients with liver cirrhosis 
resulted from bacterial infections other than SBP and who 
were hospitalized at our medical institution between 1 
January 2005 and 30 May 2008. Diagnosis of liver cir-Kim JH, et al: Renal Failure and Bacterial Infection in Liver Cirrhosis   293





  Male 58 (72.5)
  Female 22 (27.5)
Etiology 
  HBV 28 (35)
  HCV 14 (17.5)
  Alcohol 30 (37.5)
  Non-B, non-C  7 (8.8)
  PBC  1 (1.3)
Infection 
  UTI 30 (37.5)
  Biliary tract infection 16 (20.0)
  Pneumonia 19 (23.8)
  Cellulitis 10 (12.5)
  Primary bacteremia  5 (6.3)
HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary 
biliary cirrhosis; UTI, urinary tract infection.
*Mean years±SE. Other data are number (%) of patients.
rhosis was made based on clinical, radiological, or histo-
pathological findings. Diagnostic criterias for each bacte-
rial infection were as follows. Pneumonia was diagnosed 
when chest X-ray abnormalities was accompanied by fe-
ver, coughing, and leukocytosis. Urinary tract infection 
was diagnosed when fever and recurrent urinary tract 
symptoms that were positive for bacteriuria by urine cul-
ture existed. Biliary tract infection was suggested when 
fever, abdominal pain, leukocytosis, coexisted with find-
ings suggestive of biliary tract infection on ultra-
sonography or abdominal CT scans. Gastrointestinal in-
fection was defined as having vomiting, diarrhea, fever, 
abdominal pain, leukocytosis, and positive findings on a 
stool culture test. Cellulitis was defined as a skin in-
fection, fever, and leukocytosis. Bacteremia of unknown 
origin was defined as positive findings on a blood culture 
in the absence of other infectious causes.
4,8 For cases who 
had ascite, ascitic fluid culture and analysis were done to 
exclude SBP and culture-negative neutrocytic ascites.
  Renal dysfunction following bacterial infection was de-
fined as ＞50% increase in serum creatinine level over the 
base line value with abnormal peak serum creatinine level 
(＞1.5 mg/dL) after the bacterial infection was 
diagnosised.
12 Reversible renal dysfunction was defined as 
return to that of the normal value in 2 weeks of treat-
ment period after renal dysfunction occurred. For cases in 
which the serum creatinine levels did not return to that 
of the normal value in 2 weeks of treatment period or 
were persistently elevated, an irreversible renal dysfunc-
tion was diagnosed.
2. Methods
    The clinical characteristics and serum biochemistry 
findings, including age, gender, blood pressure, liver cir-
rhosis etiology, type of bacterial infection, Child-Pugh 
score, WBC count, prothrombin time, Model for End- 
Stage Liver Disease (MELD) score, and serum sodium, 
BUN, creatinine, bilirubin, and albumin concentrations 
during the course of bacterial infection, were retro-
spectively analyzed in all patients to determine risk fac-
tors for renal dysfunction. 
3. Statistical analysis
  The data are expressed as mean±standard error (SE) or 
number and percentage. Continuous variables were ana-
lyzed using independent t-test, and discontinuous varia-
bles were analyzed with Pearson’s chi-square or Fisher’s 
exact test. Multivariate analysis was performed using a 
multiple logistic regression for variables with significant 
p-values in univariate analysis. All statistical analyses 
were performed with SPSS (Windows release 10.0; SPSS 
Inc., Chicago, IL, USA). A p value ＜0.05 was considered 
significant.
RESULTS
1. Patient characteristics and overall incidence of 
renal dysfunction
  The current study was conducted with 80 patients who 
were hospitalized at our medical institution due to liver 
cirrhosis accompanied by a bacterial infection other than 
SBP. The mean age was 59.4±1.0 years; the male-to-fe-
male ratio was 7：3. Causative factors for liver cirrhosis 
included alcoholic liver disease in 30 patients, chronic 
hepatitis B in 28, chronic hepatitis C in 14, unknown 
causes in seven, and primary biliary cirrhosis in one. 
There were 30 cases of urinary tract infection, 19 cases of 
pneumonia, 16 cases of biliary tract infection, 10 cases of 
cellulites, and five cases of bacteremia of unknown origin 
(Table 1). Renal dysfunction developed in 29 (36%) of 
the patients with liver cirrhosis who concurrently had a 
bacterial infection.
2. Risk factors for developing renal dysfunction
  The clinical characteristics of the 29 patients who had 
renal dysfunction occurred after diagnosis of bacterial in-
fection and the 51 patients who did not had renal dys-
function were comparatively evaluated. The mean age was 
59.8±9.9 years in patients with renal dysfunction and 
59.1±9.5 years in patients without renal dysfunction. 294   Gut and Liver, Vol. 3, No. 4, December 2009
Table 2. Comparison of Characteristics of Groups according to Development of Renal Dysfunction
Characteristic
Patients who developed 
renal dysfunction (n=29)
Patients who did not develop 
renal dysfunction (n=51)
p-value
Age (yr)     59.8±9.9*    59.1±9.5* 0.76
Gender  0.59
  Male    20 (69)    38 (75)
  Female     9 (31)    13 (25)
Blood pressure (mmHg)
  Systolic     99.5±16.6*   110.9±15.7* 0.003
  Diastolic      64.5±10.1*    70.7±6.5* 0.004
Etiology  0.041
  HBV     7 (24)    21 (41)
  H C V     6  ( 2 1 )     8  ( 1 6 )
  Alcohol    15 (52)    15 (29)
  N o n - B ,  n o n - C     0     7  ( 1 4 )
  P B C     1  ( 3 )     0
Infection type 0.161
  UTI    15 (52)    15 (29)
  Biliary tract infection     2 (7)    14 (27)
  Pneumonia     7 (24)    12 (24)
  Cellulitis     3 (10)     7 (14)
  P r i m a r y  b a c t e r e m i a     2  ( 7 )     3  ( 6 )
Child-Pugh score      9.1±1.6*     8.4±2.1* 0.083
Laboratory data
  WBC count (/μL) 11,915.0±7,568* 7,823.5±4,525* 0.011
  Sodium (mEq/L)    133.0±6.7*   135.8±6.0* 0.056
  Bilirubin (mg/dL)      6.9±7.9*     3.9±3.4* 0.067
  Prothrombin time (%)     51.8±16.9*    58.8±20.4* 0.119
  Albumin (g/dL)      2.6±0.4*     2.9±0.5* 0.015
  MELD score     24.5±6.9*    15.8±5.7* ＜0.0001
  Creatinine (mg/dL)     0.82±0.2*    0.79±0.7* 0.096
HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary biliary cirrhosis; UTI, urinary tract infection; MELD, Model for 
End-Stage Liver Disease.
*Mean±SE. Other data are number (%) of patients.
Table 3. Multiple Logistic Regression Analysis for the 
Variables Affecting Renal Dysfunction Development after 
Bacterial Infection
Variable Odds ratio (95% CI) p-value
Systolic BP＜100 mmHg  3.272 (0.80-13.33) 0.098
Diastolic BP＜60 mmHg  5.565 (0.31-98.98) 0.242
MELD score≥20 12.609 (3.01-52.77) 0.001
Albumin＜2.8 g/dL  1.147 (0.26-5.02) 0.856
WBC count＞10,000/μL  2.184 (0.59-8.08) 0.242
Alcoholism  4.042 (0.97-16.83) 0.055
CI, confidence interval; BP, blood pressure; MELD, Model for 
End-Stage Liver Disease; WBC, white blood cell.
There were no significant differences in gender, Child- 
Pugh score, or type of bacterial infection between the two 
groups. However, systolic and diastolic pressures were 
99.5±16.6 mmHg and 64.5±10.1 mmHg, respectively, in 
29 patients who had renal dysfunction developed and 
110.9±15.7 mmHg and 70.7±6.5 mmHg, respectively, in 
51 patients who did not have renal dysfunction (p＜0.01). 
Renal dysfunction was more prevalent in patients with al-
coholic liver disease (Table 2).
  There was no significant difference in serum sodium, 
serum bilirubin, serum creatinine, or prothrombin time 
during the course of bacterial infection between the two 
groups. However, in patients with renal dysfunction, the 
WBC count (11,915/μL) and MELD score (24.5) were 
significantly higher than those in patients without renal 
dysfunction (p=0.011 and p＜0.0001, respectively). The 
albumin level also differed significantly between the 
groups (p=0.015) (Table 2).
  A multiple logistic regression analysis was performed 
on systolic and diastolic pressures, presence of alcoholic 
liver disease, WBC count, albumin level, and MELD 
score, which were all significant in the univariate analysis. 
The MELD score was significantly associated with the oc-
currence of renal dysfunction resulting from bacterial 
infection. The incidence of renal dysfunction in cases with Kim JH, et al: Renal Failure and Bacterial Infection in Liver Cirrhosis   295
Table 4. Comparison of Characteristics of Groups according to Development of Irreversible Renal Dysfunction
Characteristic
Patients who developed irreversible 
renal dysfunction (n=11)
Patients who did not develop 
irreversible renal dysfunction (n=69)
p-value
Age (yr)     63.8±7.6*     58.7±9.8* 0.103
Gender 0.985
  Male     8 (73)    50 (72)
  Female     3 (27)    19 (28)
Blood pressure (mmHg)
  Systolic      99.1±17.0*    108.0±16.6* 0.128
  Diastolic      67.2±10.1*     68.6±8.3* 0.677
Etiology 0.394
  HBV     3 (27)    25 (36)
  HCV     4 (36)    10 (14)
  Alcohol     4 (36)    26 (38)
  N o n - B ,  n o n - C     0     7  ( 1 0 )
  P B C     0     1  ( 2 )
Infection type 0.210
  UTI     5 (45)    25 (36)
  B i l i a r y  t r a c t  i n f e c t i o n     0    1 6  ( 2 3 )
  Pneumonia     3 (27)    16 (23)
  Cellulitis     1 (9)     9 (13)
  Primary bacteremia     2 (18)     3 (5)
Child-Pugh score      9.0±1.4*      8.4±1.9* 0.285
Laboratory data
  WBC count (/μL) 11,985.0±8,122 * 8,879.71±5,670* 0.246
  Sodium (mEq/L)    132.6±2.9*    135.5±6.4* 0.138
  Bilirubin (mg/dL)      6.2±6.1*      4.3±4.3* 0.361
  Prothrombin time (%)     49.3±14.5*     57.4±19.9* 0.126
  Albumin (g/dL)      2.7±0.4*      2.8±0.5* 0.214
  MELD score     27.2±7.9*     17.6±6.5* 0.003
  Creatinine (mg/dL)     0.89±0.3*     0.76±0.6* 0.073
HBV, hepatitis B virus; HCV, hepatitis C virus; PBC, primary biliary cirrhosis; UTI, urinary tract infection; MELD, Model for 
End-Stage Liver Disease.
*Mean±SE. Other data are number (%) of patients.
Table 5. Multiple Logistic Regression Analysis for the Variables 
Affecting Irreversible Renal Dysfunction after Bacterial Infection
Variable Odds ratio (95% CI) p-value
Systolic BP＜100 mmHg  2.032 (0.44-9.48) 0.367
Diastolic BP＜60 mmHg  0.295 (0.02-4.19) 0.476
MELD score≥20 12.057 (1.35-107.90) 0.026
Albumin＜2.8 g/dL  1.127 (0.21-5.97) 0.888
WBC count＞10,000/μL  3.514 (0.67-18.33) 0.136
Alcoholism  0.621 (0.12-3.23) 0.571
CI, confidence interval; BP, blood pressure; MELD, Model for 
End-Stage Liver Disease; WBC, white blood cell.
a MELD score ＞20 was 12.6 times the incidence in the 
other cases (OR, 12.609; 95% confidence interval, 3.01- 
52.77, p=0.001) (Table 3).
3. Incidence, risk factors, and prognosis of irrever-
sible renal dysfunction
  Irreversible renal dysfunction occurred in 11 patients, 
representing 14% of the total number of patients and 
38% of those who had renal dysfunction. When cases 
with reversible and irreversible renal dysfunction were 
compared, there were no statistically significant differ-
ences in variables including MELD score. However, when 
patients with irreversible renal dysfunction were com-
pared with those without irreversible renal dysfunction 
(reversible renal dysfunction and no renal dysfunction), 
the MELD score showed significant difference (p=0.003) 
(Table 4). This was in agreement with the results of the 
multivariate analysis in which only the MELD score was a 
significant risk factor for developing renal dysfunction 
(p=0.026) (Table 5).
  Of the 80 patients with bacterial infection, seven pa-
tients, all of whom had irreversible renal dysfunction oc-
curred, died during the hospitalization. There were no 
significant differences in clinical characteristics and blood 
test results between patients who died and those who did 296   Gut and Liver, Vol. 3, No. 4, December 2009
not; only the MELD score was significantly different be-
tween the two groups (p=0.004).
DISCUSSION
  Bacterial infection is one of the most common compli-
cations in patients with liver cirrhosis, and mortality has 
been higher.
1-4 Urinary tract infection, pneumonia, and 
SBP are bacterial infections commonly seen in patients 
with liver cirrhosis.
5-8
  Studies concerning bacterial infection in patients with 
liver cirrhosis have focused mainly on those with SBP. 
Renal dysfunction is concurrently present in approx-
imately one-third of SBP cases and is one of the most 
powerful indicators predicting death during the hospitali-
zation.
9 In patients with liver cirrhosis accompanied by 
ascites, there is a concurrent presence of circulatory dys-
function characterized by arterial dilatation, hypotension, 
increased cardiac output, and decreased effective circulat-
ing volume. In patients with liver cirrhosis and con-
current SBP, cytokine (TNF-alpha and IL-6) and nitric ox-
ide levels are elevated, resulting in the dilatation of blood 
vessels and decreased renal blood flow. The deterioration 
of compensatory mechanisms leads to renal dysfunc-
tion.
9,13 I t  i s  w e l l  k n o w n  t h a t  a l b u m i n  i n f u s i o n  c a n  p r e -
vent renal dysfunction and enhance survival in patients 
with liver cirrhosis and concurrent SBP.
10,14 In all types of 
bacterial infection, the increased release of inflammatory 
cytokines and vasodilatory substances can lead to renal 
dysfunction and circulatory dysfunction.
  According to a recent study, there was a concurrent 
presence of bacterial infection, including SBP, in 44.6% of 
hospitalized patients with liver cirrhosis and ascites. Of 
these, 33.6% had renal dysfunction.
15 Other studies have 
reported renal dysfunction in 26% of patients who con-
currently had a bacterial infection other than SBP.
16 In 
our series, in which SBP was excluded, renal dysfunction 
occurred in 36% of all patients, which is close to the in-
cidence of renal dysfunction previously reported in pa-
tients with liver cirrhosis and bacterial infection include 
SBP.
  In our study, type of bacterial infection were similar to 
the recent studies,
5-8 urinary tract infection was the most 
common, followed by pneumonia and biliary tract infec-
tion. In a recent study, renal dysfunction reportedly oc-
curred more frequently in patients with biliary tract in-
fection,
15 however, we found no significant difference in 
the occurrence of renal dysfunction based on the type of 
infection.
  The improvement in infection is well-known indepen-
dent risk factors for developing renal dysfunction in pa-
tients with liver cirrhosis who concurrently have a bacte-
rial infection.
14 The MELD score is the best prognostic 
marker of patients with cirrhosis and sepsis.
16 Other 
study which have examined renal dysfunction after SBP, 
reported that blood urea nitrogen, serum sodium concen-
tration before peritonitis and band neutrophils count in 
blood at diagnosis were independent predictors for the 
development renal dysfunction.
9 In the present study, the 
only risk factor identified for developing renal dysfunction 
was the MELD score, indicating that severe hepatic dys-
function is a risk factor for developing renal dysfunction 
in patients with liver cirrhosis and bacterial infection. 
Patients with liver cirrhosis in whom renal dysfunction 
occurred due to bacterial infections other than SBP had a 
poor prognosis; the hospitalization mortality rate is 
42.8% (7.24% in cases without renal dysfunction),
15 and 
the 3-month mortality is 66% (13% in cases without re-
nal dysfunction).
16 Particularly in cases with irreversible 
renal dysfunction, the 3-month mortality may reach 
100%. In our series, the hospitalization mortality was 
24% in patients who developed renal dysfunction, and all 
those who died during the hospitalization had developed 
irreversible renal dysfunction. The MELD score was a fac-
tor for predicting hospitalization death.
  In summary, renal dysfunction occurred in 36% of pa-
tients with liver cirrhosis who developed a bacterial in-
fection other than SBP. The MELD score was the only 
factor that independently predicted the occurrence of re-
nal dysfunction. Patients with liver cirrhosis who con-
currently had a bacterial infection and renal dysfunction 
had a poor prognosis. In particular, the prognosis was 
poor for those with irreversible renal dysfunction.
   There were several limitations to the current study. 
This was retrospective in design and lacked data about 
the use of plasma expanders. Further studies are war-
ranted to examine whether albumin treatment can pre-
vent the occurrence of renal dysfunction and enhance sur-
vival in patients with bacterial infections other than SBP. 
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